Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The lose of Brian and Wolf will hurt the value of this message board.

OK. We're on the same page, just getting lost in the translation, though I do think there is latitude in what constitutes a 3rd party expense, versus in-house charges, and the 2-1 TPL representation on the management committee certainly wouldn't have hurt TPL's ability to game the system I think the language leaves open a lot of opportunity for TPL to constructively present certain charges as 3rd-party, when most would consider them ordinary course of business in-house charges.

Granting your view of the charges, the exposure I'm concerned about is still there. See my last post to opty as to why this is an important issue IMO.

Share
New Message
Please login to post a reply